The New York Genome Center is the latest healthcare organization to take advantage of the cognitive learning capabilities of the IBM Watson supercomputer. During the past year, Memorial Sloan-Kettering Cancer Center has been feeding medical literature on cancer over three decades to Watson, teaching the computer how cancer has been traditionally treated without the benefits of whole genome sequencing. With the benefit of that knowledge, New York Genome Center and IBM are developing a new Watson
Watson Supercomputer to Help Personalize Oncology Treatment
MAR 20, 2014 12:45pm ET
To continue, please log in or register.